We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$452M
AUM Growth
+$130M
(+40%)
Cap. Flow
-$18.5M
Cap. Flow
% of AUM
-4.08%
Top 10 Holdings %
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
+$3.03M |
| 2 |
OneSpan
OSPN
|
+$2.96M |
| 3 |
Anterix
ATEX
|
+$2.79M |
| 4 |
Calix
CALX
|
+$2.73M |
| 5 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
+$2.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axsome Therapeutics
AXSM
|
+$3.54M |
| 2 |
Karyopharm Therapeutics
KPTI
|
+$3.44M |
| 3 |
Teladoc Health
TDOC
|
+$3.2M |
| 4 |
Krystal Biotech
KRYS
|
+$3M |
| 5 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
+$2.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.95% |
| 2 | Technology | 21.89% |
| 3 | Consumer Discretionary | 16.2% |
| 4 | Industrials | 10.05% |
| 5 | Consumer Staples | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVTA
76
DELISTED
Invitae Corporation
NVTA
| $2.08M | 0.46% |
+68,680
| New | +$1.2M |
|
77
Etsy
ETSY
$8.15B
| $2.08M | 0.46% |
+19,553
| New | +$1.45M |
|
|
AXON
78
Axon Enterprise
AXON
$49.1B
| $2.06M | 0.46% |
20,984
-3,644
| -15% | -$295K |
|
79
Wingstop
WING
$3.37B
| $2.06M | 0.45% |
+14,809
| New | +$1.73M |
|
80
Yeti Holdings
YETI
$3.98B
| $2.04M | 0.45% |
+47,748
| New | +$1.43M |
|
|
MNTA
81
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $2.04M | 0.45% |
61,218
+962
| +2% | +$30.6K |
|
82
Natera
NTRA
$39.3B
| $2.02M | 0.45% |
+40,493
| New | +$1.63M |
|
|
SMED
83
DELISTED
Sharps Compliance Corp
SMED
| $2.02M | 0.45% |
286,888
-20,811
| -7% | -$148K |
|
|
LVGO
84
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $2M | 0.44% |
+26,662
| New | +$1.4M |
|
85
BJ's Restaurants
BJRI
$1.44B
| $1.98M | 0.44% |
+94,549
| New | +$1.87M |
|
86
Simpson Manufacturing
SSD
$8.12B
| $1.97M | 0.44% |
+23,400
| New | +$1.73M |
|
|
BLD
87
DELISTED
TopBuild
BLD
| $1.96M | 0.43% |
+17,259
| New | +$1.72M |
|
|
HZNP
88
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.96M | 0.43% |
+35,311
| New | +$1.51M |
|
89
Pacira BioSciences
PCRX
$979M
| $1.95M | 0.43% |
+37,137
| New | +$1.55M |
|
|
ZYXI
90
DELISTED
Zynex
ZYXI
| $1.91M | 0.42% |
84,643
-44,089
| -34% | -$738K |
|
91
Arcturus Therapeutics
ARCT
$178M
| $1.9M | 0.42% |
+40,695
| New | +$1.4M |
|
|
IMMU
92
DELISTED
Immunomedics Inc
IMMU
| $1.9M | 0.42% |
+53,540
| New | +$1.57M |
|
93
Generac Holdings
GNRC
$12.8B
| $1.89M | 0.42% |
15,490
-13,819
| -47% | -$1.46M |
|
94
SPS Commerce
SPSC
$2.61B
| $1.89M | 0.42% |
+25,150
| New | +$1.53M |
|
95
BJs Wholesale Club
BJ
$12.3B
| $1.89M | 0.42% |
+50,660
| New | +$1.56M |
|
96
Fastly Inc
FSLY
$4.07B
| $1.88M | 0.42% |
+22,121
| New | +$872K |
|
97
Cloudflare
NET
$104B
| $1.88M | 0.42% |
52,355
-38,521
| -42% | -$1.08M |
|
98
Acadia Pharmaceuticals
ACAD
$4.93B
| $1.87M | 0.41% |
+38,555
| New | +$1.85M |
|
|
NUAN
99
DELISTED
Nuance Communications, Inc.
NUAN
| $1.86M | 0.41% |
73,618
-35,750
| -33% | -$747K |
|
|
AGNT
100
AGNT Inc
AGNT
$666M
| $1.85M | 0.41% |
+217,218
| New | +$1.11M |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q2 2020 Portfolio in Review
As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.
- EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
- EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
- EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
- EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
- EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
- EAM Investors opened 147 new positions and closed 97 in Q2 2020.
- EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.
Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.